Photonics Healthcare

Executive Summary

Photonics Healthcare is a Dutch medical device company that has developed the COMET system, a non-invasive bedside device that measures mitochondrial oxygen availability in real-time. Founded in 2016, the company addresses the critical need for early detection of cellular hypoxia, which can lead to organ failure if untreated. The CE-marked COMET system provides clinicians with actionable data to guide interventions, potentially improving patient outcomes in settings such as ICUs, operating rooms, and emergency departments. The global market for non-invasive monitoring devices is expanding, driven by increasing demand for early diagnosis and personalized medicine. Photonics Healthcare's unique technology, which directly assesses mitochondrial function rather than downstream oxygen levels, offers a distinct competitive advantage. However, the company faces challenges in commercialization, including adoption by healthcare providers, reimbursement hurdles, and competition from established monitoring modalities. If successfully scaled, COMET could become a standard-of-care tool for assessing tissue oxygenation.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for COMET system in the US market60% success
• Q2 2026Publication of clinical validation study in a peer-reviewed journal demonstrating improved patient outcomes80% success
• Q3 2026Strategic partnership with a major medical device company for distribution50% success